Posted by Michael Wonder on 08 Mar 2022
FDA effort to improve clinical trial diversity failed to make a difference for Black patients, study finds
7 March 2022 - Six years ago, the U.S. FDA launched a five year action plan to improve the diversity and transparency of pivotal clinical trials for newly approved medicines.
But a new analysis finds the effort failed to make a difference for black patients, whose participation in clinical trials remained inadequate.
